Delivery Order SPE2DB20D1109-SPE2DB25FN33X

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,013.18 firm fixed-price delivery order is for the supply of 4,565,426,321 units of 125 mcg Synthroid tablets. The contract has an ultimate completion date of August 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the supply of 90 tablets of Synthroid 125 mcg, a prescription medication, with a potential value of $3,123.86 and a completion date of February 5, 2024. The contract does not have a set-aside designation....
This federal contract award is for the delivery of Synthroid 25 MCG tablets in 1,000 count packages to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. This is a firm fixed-price delivery order contract with a ceiling value of $1,462.38 and a completion date of May 14, 2024. The contract is not a set-aside award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Synthroid 100 mcg tablets. The $2,090.34 firm-fixed-price delivery order has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,441.77, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Synthroid 112 mcg tablets in quantities of 1,000 to support military treatment programs and facilities. It is a firm fixed price delivery order with an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. The award to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is for the supply of 4,565,951,410 Synthroid 125mcg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $3,560.68 and a completion date of September 26, 2024. This delivery order does not utilize a...
The Defense Logistics Agency (DLA) awarded a $11,495.75 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 125 mcg Synthroid tablets. This contract does not have a set-aside designation and has an ultimate completion date of September 12, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $16,191.93, is a firm fixed price agreement for the delivery of Synthroid 50 mcg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running...
This federal contract award is for the delivery of Synthroid 50 mcg tablets in quantities of 1,000 to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,032.72, was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 1,000 units of Synthroid 25 mcg tablets. The $2,729 firm fixed-price delivery order has an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN33X
    Delivery Order

This federal contract award, valued at $1,581.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Synthroid 125 mcg tablets. The contract has an ultimate completion date of January 3, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/3/25, 10:16 AM